Dietary Supplement Recall Update As FDA Sets Risk Level
A Vitamin B supplement has been recalled due to being incorrectly formulated with niacin rather than niacinamide.
Axios on MSN5h
Abortion pills may be FDA's first test under Trump
While the early focus on a Trump administration Food and Drug Administration has been on vaccine policy, one of its first ...
Benefits Pro54m
Pharmacies lobby FDA for right to keep making weight-loss drugs
Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...
FDA's New Rules Require TV Drug Ads to Be Clearer, More Direct
The U.S. Food and Drug Administration ( FDA) now requires TV and radio drug ads to be clearer and more direct. The new ...
Food Safety News2d
FDA doubles down on import enforcement for mycotoxins, heavy metals and more
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries.
STAT3d
FDA commissioner: We need action and higher-quality research on ultra-processed foods
Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...
US FDA approves Syndax's blood cancer drug
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
Food Safety News12h
FDA cites Chinese canned tuna facility for major HACCP violations following inspection
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...
FDA approves Syndax’s Revuforj to treat leukaemia
The US Food and Drug Administration (FDA) has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating relapsed or ...
WBRC FOX6 News4d
FDA bans certain synthetic dye from cosmetics but allows in food, advocate calls it ‘illogical’
BIRMINGHAM, Ala. (WBRC) - The U.S. Food and Drug Administration (FDA) does not allow Red No. 3 to be used in ...
Renal & Urology News11m
Pan-Amyloid Removal Therapeutic Gets Orphan Drug Status for Systemic Amyloidosis
Preclinical studies have shown AT-02 is able to bind to multiple amyloid types and can induce macrophage mediated amyloid phagocytosis and removal. The Food and Drug Administration has granted Orphan ...
CCHR Int2d
CCHR Urges FDA Overhaul to End Psychiatric Drug and Device Harms
The Mental Health Watchdog calls for reforms to protect public safety, citing decades of antidepressant, electroshock, and psychedelic drug risks.